New anesthesia drug may offer safer sedation for heart valve patients
NCT ID NCT05881291
First seen Jan 16, 2026 · Last updated May 13, 2026 · Updated 18 times
Summary
This study tested a new sedative called ciprofol against the standard drug propofol for patients undergoing a minimally invasive heart valve replacement (TAVR). The goal was to see if ciprofol causes fewer drops in blood pressure after anesthesia. 124 older adults (ages 60-85) participated. The results could help make anesthesia safer for this high-risk group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSCATHETER AORTIC VALVE REPLACEMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Affiliated Hospital of Zhejiang University anesthesiology department
Hangzhou, Zhejiang, 310000, China
Conditions
Explore the condition pages connected to this study.